DK1591122T3 - Fremgangsmåde til indgivelse af bisphosphonater - Google Patents

Fremgangsmåde til indgivelse af bisphosphonater

Info

Publication number
DK1591122T3
DK1591122T3 DK05012711.7T DK05012711T DK1591122T3 DK 1591122 T3 DK1591122 T3 DK 1591122T3 DK 05012711 T DK05012711 T DK 05012711T DK 1591122 T3 DK1591122 T3 DK 1591122T3
Authority
DK
Denmark
Prior art keywords
bisphosphonates
administration
Prior art date
Application number
DK05012711.7T
Other languages
English (en)
Inventor
Zebulun D Horowitz
Peter C Richardson
Ulrich Trechsel
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=32595500&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1591122(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Priority claimed from EP01940580A external-priority patent/EP1296689B3/en
Application granted granted Critical
Publication of DK1591122T3 publication Critical patent/DK1591122T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/662Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
    • A61K31/663Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK05012711.7T 2000-06-20 2001-06-18 Fremgangsmåde til indgivelse af bisphosphonater DK1591122T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US59713500A 2000-06-20 2000-06-20
US26768901P 2001-02-09 2001-02-09
EP01940580A EP1296689B3 (en) 2000-06-20 2001-06-18 Method of administering bisphosphonates

Publications (1)

Publication Number Publication Date
DK1591122T3 true DK1591122T3 (da) 2013-02-25

Family

ID=32595500

Family Applications (1)

Application Number Title Priority Date Filing Date
DK05012711.7T DK1591122T3 (da) 2000-06-20 2001-06-18 Fremgangsmåde til indgivelse af bisphosphonater

Country Status (6)

Country Link
EP (1) EP1591122B1 (da)
DK (1) DK1591122T3 (da)
LU (1) LU92174I2 (da)
RU (1) RU2288722C2 (da)
SI (2) SI1296689T1 (da)
ZA (1) ZA200210361B (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN2012DN00845A (da) * 2009-07-21 2015-06-26 Mylan Inc
US20160016982A1 (en) 2009-07-31 2016-01-21 Thar Pharmaceuticals, Inc. Crystallization method and bioavailability
US9169279B2 (en) 2009-07-31 2015-10-27 Thar Pharmaceuticals, Inc. Crystallization method and bioavailability
DK2459176T3 (da) 2009-07-31 2017-12-04 Gruenenthal Gmbh Krystallisationsfremgangsmåde og biotilgængelighed
RU2415145C1 (ru) * 2009-09-15 2011-03-27 Закрытое Акционерное Общество "Фарм-Синтез" Способ получения золедроновой кислоты
US9340565B2 (en) 2010-11-24 2016-05-17 Thar Pharmaceuticals, Inc. Crystalline forms
US10195218B2 (en) 2016-05-31 2019-02-05 Grunenthal Gmbh Crystallization method and bioavailability

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5A (en) * 1836-08-10 Thomas Blanchard Machine for mortising solid wooden shells of ships' tackle-blocks
US4A (en) * 1836-08-10 Thomas Blanchard Stock shaving or rounding machine for edges ends etc of ships' tackle-blocks
ES2038692T4 (es) 1986-11-21 2012-02-10 Novartis Ag Procedimiento para la obtencion de acidos alcanodifosfonicos substituidos.
CA2188066C (en) * 1992-05-29 2000-12-05 Susan Mary Kaas Thio-substituted phosphonate compounds
GB9408775D0 (en) 1994-05-04 1994-06-22 Ciba Geigy Ag Use of certain methanebisphosphonic acid derivatives to prevent prothesis loosening and prothesis migration
US6015801A (en) * 1997-07-22 2000-01-18 Merck & Co., Inc. Method for inhibiting bone resorption
PT1175904E (pt) * 1997-07-22 2007-04-30 Merck & Co Inc Alendronato para utilização no tratamento da osteoporose
FI109088B (fi) * 1997-09-19 2002-05-31 Leiras Oy Tabletti ja menetelmä sen valmistamiseksi
SE9703691D0 (sv) * 1997-10-10 1997-10-10 Astra Ab Pharmaceutical compositions
IT1296495B1 (it) * 1997-11-21 1999-06-25 Prodotti Antibiotici Spa Impiego di bisfosfonati nella preparazione di forme farmaceutiche per somministrazione intramuscolare
PL351674A1 (en) * 1999-05-21 2003-05-19 Novartis Ag Use of bisphosphonic acids for treating angiogenesis

Also Published As

Publication number Publication date
RU2288722C2 (ru) 2006-12-10
EP1591122A1 (en) 2005-11-02
LU92174I2 (fr) 2013-05-22
SI1296689T1 (sl) 2006-08-31
ZA200210361B (en) 2003-11-13
EP1591122B1 (en) 2012-09-26
SI1591122T1 (sl) 2013-02-28

Similar Documents

Publication Publication Date Title
DK1296935T3 (da) Fremgangsmåde til fremstilling af substituerede octanoylamider
DK1296656T3 (da) Fremgangsmåde til fremstilling af et præparat
DK1259512T3 (da) Pteridinforbindelser til behandling af psoreasis
DK1253153T3 (da) Fremgangsmåde til fremstilling af 4"-substituerede-9-deoxo-9a-aza-9a-homoerythromycin-A-derivater
DK1303478T3 (da) Fremgangsmåde til fremstilling af substituerede octanoylamider
DK1326585T4 (da) Fremgangsmåde til fremstilling af pulverformuleringer
DK1309545T3 (da) Fremgangsmåde til fremstilling af alkylarylsulfonater
DK1277722T3 (da) Fremgangsmåde til fremstilling af methanol
DK1165576T3 (da) Fremgangsmåde til fremstilling af amin-platin-komplekser
DK1381351T3 (da) Fremgangsmåde til kontinuerlig fremstilling af inhalerbare medikamenter
DK1349580T4 (da) Fremgangsmåde til forbedring af stabiliteten af en farmaceutisk sammensætning
DK1282616T3 (da) Hydroxyphenylpiperidin-4-ylidenmethylbenzamidderivater til behandling af smerter
DK1147075T3 (da) Fremgangsmåde til fremstilling af L-phenylephrinhydrochlorid
DK1345939T3 (da) Fremgangsmåde til fremstilling af sulfonamidsubstituerede imidazotriazinoner
DK1263717T3 (da) Fremgangsmåde til fremstilling af methionin
DK1373255T3 (da) Fremgangsmåde til fremstilling af imidazolforbindelser
DK1326836T3 (da) Fremgangsmåde til fremstilling af 3-amino-2-chlor-4-methylpyridin
DK1456229T3 (da) Fremgangsmåe til fremstilling af echinocandin-derivater
DK1446107T3 (da) Fremgangsmåde til fremstilling af tabletter omfattende s-adenosylmethionin
DK1353930T3 (da) Fremgangsmåde til fremstilling af N-phosphonomethyliminodieddikesyre
DK1292586T3 (da) Fremgangsmåde til fremstilling af pyrazolopyrimidinoner
DK1591122T3 (da) Fremgangsmåde til indgivelse af bisphosphonater
DK1257557T3 (da) Fremgangsmåde til fremstilling af N-(phosphonomethyl)glycin
DK1203000T3 (da) Fremgangsmåde til fremstilling af phosphonomethylglycin
DK1401846T3 (da) Fremgangsmåde til udvinding af N-phosphonomethylglycin